Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12090175
Compositions and methods for tissue repair with extracellular matrices
granted -
US 12090139
Formulations comprising triptan compounds
granted -
US 12090126
Methods of administering solriamfetol to lactating women
granted -
US 12090140
Non-sedating dexmedetomidine treatment regimens
granted -
US 12090193
Glucagon-like peptide 1 receptor agonists and uses thereof
granted -
US 12084473
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 12084489
Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection
granted -
US 12084490
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
granted -
US 12084497
SIRP1α targeted chimeric proteins and uses thereof
granted -
US 12084481
HV1 modulators and uses
granted -
US 12084502
CD33-binding polypeptides and uses thereof
granted -
US 12084659
Modulatory polynucleotides
granted -
US 12084516
Anti-C5 antibody combinations and uses thereof
granted -
US 12082565
Non-human animals models of retinoschisis
granted -
US 12084677
Methods of recellularizing a tissue or organ for improved transplantability
granted -
US 12084670
Regulating alkaloids
granted -
US 12084515
Compositions and methods for treatment of diabetic macular edema
granted -
US 12084691
Modulating human Cas9-specific host immune response
granted -
US 12084727
Microbiome markers and therapies for autism spectrum disorders
granted -
US 12084403
Linkers for antibody drug conjugates
granted -
US 12084514
Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof
granted -
US 12083141
Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors
granted -
US 12084438
GCN2 inhibitors and uses thereof
granted -
US 12084504
Anti-MET antibodies and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.